26 research outputs found
Prevalence of essential tremor in urban Lagos, Nigeria: a door-to-door community-based study
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells
INTRODUCTION: Cancer is a leading cause of death in Americans. We have identified an inducible cancer avoidance mechanism in cells that reduces mutation rate, reduces and delays carcinogenesis after carcinogen exposure, and induces apoptosis and/or senescence of already transformed cells by simultaneously activating multiple overlapping and redundant DNA damage response pathways. METHODS: The human breast carcinoma cell line MCF-7, the adriamycin-resistant MCF-7 (Adr/MCF-7) cell line, as well as normal human mammary epithelial (NME) cells were treated with DNA oligonucleotides homologous to the telomere 3' overhang (T-oligos). SCID mice received intravenous injections of MCF-7 cells followed by intravenous administration of T-oligos. RESULTS: Acting through ataxia telangiectasia mutated (ATM) and its downstream effectors, T-oligos induced apoptosis and senescence of MCF-7 cells but not NME cells, in which these signaling pathways were induced to a far lesser extent. In MCF-7 cells, experimental telomere loop disruption caused identical responses, consistent with the hypothesis that T-oligos act by mimicking telomere overhang exposure. In vivo, T-oligos greatly prolonged survival of SCID mice following intravenous injection of human breast carcinoma cells. CONCLUSION: By inducing DNA damage-like responses in MCF-7 cells, T-oligos provide insight into innate cancer avoidance mechanisms and may offer a novel approach to treatment of breast cancer and other malignancies
The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide
Migraine, Chronic Tension-Type Headache, and Cluster Headache in An Ethiopian Rural Community
Valores normais das velocidades de condução nervosa em um grupo de 101 pessoas
Foram estudadas as medidas de condução nervosa em 101 pessoas normais, 53 do sexo masculino e 48 do feminino. A idade variou de 16 a 81 anos (média, 44 anos). Foram estudadas tanto a velocidade de condução sensitiva quanto a velocidade de condução motora nos nervos mais frequentemente avaliados em neurofisiologia clínica. Em relação ao fator idade, observou-se declínio significativo nas faixas etárias mais avançadas
